Dopamine receptors have been divided into two families, known as D-1 a
nd D-2, based on their ability to bind distinct ligands, and their use
of separate post-synaptic transduction systems. Determining the speci
fic cellular location for these dopamine receptors in the striatum is
important to the design of drug treatments for disorders with suspecte
d dopaminergic involvement such as Parkinson's disease. This study exa
mined the binding of D-1 and D-2 antagonist ligands on identified stri
atonigral neurons using in vitro fluorescent techniques. The results i
ndicate that striatonigral neurons express both pharmacological subfam
ilies of dopamine receptor binding sites.